Milestone to host webcast Nov 13 on etripamil Phase 2 AFib-RVR study results

Milestone Pharmaceuticals Inc.

Webcast on Monday Nov 13, 2023 at 8:00 a.m. ET to discuss ReVeRA Phase 2 results of etripamil in AFib-RVR.
Key opinion leaders A. John Camm, MD, and Sean Pokorney, MD, will join the webcast.
Results presented as Featured Science at AHA Scientific Sessions 2023.
Dial-in: (877) 870-4263 (domestic) or (412) 317-0790 (international).
Webcast and slides accessible via News & Events section of Milestone's IR website.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.